Haixia Li
- Microbiology top 5%
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes 10
- Dialysis and Renal Disease Management 5
- Renal Diseases and Glomerulopathies 4
- Obstetrics and Gynecology top 10%
-
- Cancer-related molecular mechanisms research 3
-
- Bladder and Urothelial Cancer Treatments 3
-
- Renal cell carcinoma treatment 2
-
- Neonatal Health and Biochemistry 2
-
- Pancreatic and Hepatic Oncology Research 2
- Co-authors
- Haiming HuangChen‐Wei HuangLi‐Ying SunLei HuangHong‐Yun YangQingyu WuJunqing ZhangZhao Wang
- Journals
- PLoS ONE (3 papers)Biochemical and Biophysical Research Communications (1 paper)Hypertension (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Haixia Li
59 papers receiving 882 citations
Peers
Comparison fields: 5 of 127
- Microbiology 29
- Nephrology 85
- Obstetrics and Gynecology 79
- Applied Microbiology and Biotechnology 18
- Cancer Research 84
Countries citing papers authored by Haixia Li
This map shows the geographic impact of Haixia Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haixia Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haixia Li more than expected).
Fields of papers citing papers by Haixia Li
This network shows the impact of papers produced by Haixia Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haixia Li. The network helps show where Haixia Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haixia Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 9 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 16 | |
| 10 | 2020 | 41 | |
| 11 | 2020 | 6 | |
| 12 | 2020 | 13 | |
| 13 | 2017 | 34 | |
| 14 | 2016 | 30 | |
| 15 | 2015 | 1 | |
| 16 | 2014 | 70 | |
| 17 | 2014 | 8 | |
| 18 | 2009 | 9 | |
| 19 | 2009 | 16 | |
| 20 | 2003 | 76 |
About Haixia Li
Haixia Li is a scholar working on Nephrology, Microbiology and Reproductive Medicine, having authored 65 papers that have together received 896 indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (10 papers), Dialysis and Renal Disease Management (5 papers), Renal Diseases and Glomerulopathies (4 papers), Cancer-related molecular mechanisms research (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Renal cell carcinoma treatment (2 papers), Neonatal Health and Biochemistry (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Microbiology (29 citations), Nephrology (85 citations) and Obstetrics and Gynecology (79 citations). Haixia Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Haiming Huang, Chen‐Wei Huang, Li‐Ying Sun, Lei Huang, Hong‐Yun Yang, Qingyu Wu, Junqing Zhang, Zhao Wang, Yanze Liu and Junqiang Qiu. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.